Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:51 PM
Ignite Modification Date:
2025-12-24 @ 10:51 PM
NCT ID:
NCT00919269
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed diagnosis of 1 of the following:
* Rhabdomyosarcoma
* Non-rhabdomyosarcoma soft tissue sarcoma
* Chordoma
* Desmoid fibromatosis
* Desmoplastic round cell tumors
* Undifferentiated embryonal sarcoma of the liver
* Unclassified soft tissue sarcoma that is too undifferentiated to be placed in a specific pathologic category in the WHO classification (often called ?undifferentiated soft tissue sarcoma? or ?soft tissue sarcoma NOS?)
* Other soft tissue neoplasms, excluding benign tumors
* Must have pathological specimens of tumor-containing tissue or bone marrow (beyond that needed by the institution for diagnosis) available for study
* No malignant rhabdoid tumor, Ewing sarcoma/primitive neuroectodermal tumor, or osteogenic sarcoma of bone
* No osteogenic sarcoma
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
50 Years
Study:
NCT00919269
Study Brief:
Protocol Section:
NCT00919269